The global Metabolomics market is projected to exceed US$3.1 billion by 2024, driven by expanding applications for the technology, as well as increasing R&D activity in the lifesciences industry to utilize Metabolomics as a viable tool in drug discovery.
Metabolomics is a dynamic concept and a newly emerging field of omic sciences. Metabolomics is the study of chemical processes involving metabolites and provides information on the chemical fingerprints of various cellular processes. Metabolites are small molecules contained in tissues, blood and urine. Metabolomics of biological specimens derived from urine, blood and cells are relatively cheap and less invasive. The concept of Metabolomics emerged as a research tool that complements all other “omics” technologies at the metabolite level. Metabolomics or Metabolite Profiling provides a more holistic view of the phenotype of organelles, organs, tissues, cells and whole organisms, when compared to DNA, RNA, or protein profile. With proteomic and genomic analysis proving inadequate in offering comprehensive information, researchers are shifting focus onto metabolic profiling to gain detailed insights into the cell’s physiology. Metabolomics has evolved rapidly in recent years in- sync with advances in separation and analysis technologies related to mass spectroscopy (MS) and nuclear magnetic resonance (NMR) based detection techniques. Metabolomics offers potential for high growth, primarily due to the effervescent technological developments in the fields of molecular biology and biochemistry. The technology is in an evolutionary stage in the field of analytical biochemistry and is likely to witness higher growth in the coming years driven by increased adoption in drug development processes and for using the research data in drug filing as well as for the optimization of lifecycle management of commercialized drugs.
The research report titled ” Global Metabolomics Market Analysis: 2018-2024″ announced by GMR Analytics, provides a comprehensive review of trends, issues, and strategic industry activities of major companies worldwide. The report provides market estimates and projections for geographic markets such as the United States, Canada, Japan, Europe (France, Germany, Italy, UK, Spain and Rest of Europe), Asia-Pacific (China, India and Rest of Asia-Pacific), Middle East & Africa and Latin America (Brazil, Mexico and Rest of Latin America).